Sanofi Accounts Payable from 2010 to 2024

SNY Stock  USD 48.35  0.07  0.14%   
Sanofi ADR Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 3.7 B in 2024. Accounts Payable is the amount Sanofi ADR owes to suppliers or vendors for products or services received but not yet paid for. It represents Sanofi ADR's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2000-12-31
Previous Quarter
7.3 B
Current Value
7.4 B
Quarterly Volatility
3.4 B
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 607 M or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 3.95, Dividend Yield of 0.0232 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Sanofi ADR over the last few years. An accounting item on the balance sheet that represents Sanofi ADR obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Sanofi ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Sanofi ADR's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Sanofi Accounts Payable Regression Statistics

Arithmetic Mean4,318,087,594
Geometric Mean3,872,577,889
Coefficient Of Variation38.84
Mean Deviation1,253,263,258
Median3,999,000,000
Standard Deviation1,676,953,425
Sample Variance2812172.8T
Range6.7B
R-Value0.78
Mean Square Error1192568.6T
R-Squared0.61
Significance0.0006
Slope291,957,848
Total Sum of Squares39370419.1T

Sanofi Accounts Payable History

20243.7 B
20237.3 B
20226.8 B
20216.2 B
2020B
20195.3 B
2018B

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable7.3 B3.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.